Dr. David O'Malley, MD
Claim this profileOhio State University Comprehensive Cancer Center
Studies Ovarian Cancer
Studies Cancer
12 reported clinical trials
27 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
BRCA positive
Stage III
2Cancer
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials David O'Malley, MD is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
More about David O'Malley, MD
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David O'Malley, MD has experience with
- Paclitaxel
- Bevacizumab
- Pembrolizumab
- NovoTTF-100L(O)
- Tucatinib
- Trastuzumab
Breakdown of trials David O'Malley, MD has run
Ovarian Cancer
Cancer
Serous Cystadenocarcinoma
Endometrioid Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David O'Malley, MD specialize in?
David O'Malley, MD focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are BRCA positive.
Is David O'Malley, MD currently recruiting for clinical trials?
Yes, David O'Malley, MD is currently recruiting for 3 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that David O'Malley, MD has studied deeply?
Yes, David O'Malley, MD has studied treatments such as Paclitaxel, Bevacizumab, Pembrolizumab.
What is the best way to schedule an appointment with David O'Malley, MD?
Apply for one of the trials that David O'Malley, MD is conducting.
What is the office address of David O'Malley, MD?
The office of David O'Malley, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.